Want to see RLYB full AI Analyst Report?
Rallybio (RLYB) Income Statement
Rallybio Income Statement
Last quarter (Q3 2026), Rallybio's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q3, Rallybio's net income was $-2.73M. See Rallybio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 858.00K | $ 636.00K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 766.00K | $ -38.87M | $ -150.00K | $ 0.00 | $ -109.00K | |
| $ 28.83M | $ 21.63M | $ 78.93M | $ 67.88M | $ 45.65M | |
| Depreciation and Amortization | $ 92.00K | $ 131.00K | $ 150.00K | $ 167.00K | $ 109.00K |
| $ -27.97M | $ -60.37M | $ -78.78M | $ -67.72M | $ -45.39M | |
| $ -28.06M | $ -60.50M | $ -78.93M | $ -67.88M | $ -45.65M | |
| $ 19.09M | $ 2.72M | $ 4.37M | $ 1.23M | $ -1.36M | |
| $ -8.98M | $ -57.77M | $ -74.56M | $ -66.65M | $ -47.01M | |
| $ -8.98M | $ -57.77M | $ -74.56M | $ -66.65M | $ -47.01M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.59 | $ -10.64 | $ -14.72 | $ -16.72 | $ -11.68 |
| Diluted EPS | $ -1.59 | $ -10.64 | $ -14.72 | $ -16.72 | $ -11.68 |
| Weighted Average Shares Outstanding | 5.63M | 5.44M | 5.06M | 3.98M | 4.02M |
| Weighted Average Shares Outstanding (Diluted) | 5.63M | 5.44M | 5.06M | 3.98M | 4.02M |
Currency in USD